Heliox om arbetet med andning hos vuxna patienter med stenos i nedre luftvägar
Effekten av Heliox på andningsarbetet hos vuxna patienter med stenos i nedre luftvägar
Heliox (a mixture of Helium and Oxygen) can reduce the work of breathing in patients with airway stenosis by modifying turbulent flow into laminar flow. The aim of this study was to analyze the effect of Heliox versus conventional oxygen therapy in patients with lower airway stenosis on muscular effort measured by electromyography and diaphragmatic ultrasound, thoracoabdominal synchrony assessed with plethysmographic bands, dyspnea, stridor, oxygen saturation, transcutaneous carbon dioxide value, blood pressure, heart rate and respiratory rate.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Lower airway stenosis results in increased work of breathing with stridor and dyspnea, as a consequence of the increased resistances caused by the reduction in airway diameter. Airway resistance also depends on the length of the airway and the type of gas flow. Heliox (a mixture of Helium and Oxygen) is a gas less dense than air, which can change the flow from turbulent to laminar, reducing airway resistance by 20 to 40%, and therefore decreasing the work of breathing. Heliox is an inert gas that does not react with biological membranes, so there are few complications associated with its use, the most relevant being hypoxemia when fixed mixtures are not used and the the fraction of inspired oxygen (FiO2) supplied is less than 21%. The aim of the study was to evaluate if during the perioperative period of lower airway stenosis the administration of Heliox compared to oxygen could reduce the work of breathing and improve dyspnea. For this purpose, patients were treated for 30 minutes with Heliox (fixed mixture of 70% helium and 30% oxygen) using a non rebreather mask or reservoir bag versus 30 minutes with oxygen 31% using a Venturi mask.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Madrid
-
Madrid, Madrid, Spanien, 28041
- Marta Corral Blanco
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Patients will be recluted from the pneumology outpatient clinic of the Hospital 12 de Octubre
Beskrivning
Inclusion Criteria:
- Patients with lower airway stenosis evaluated at the Respiratory Endoscopy Unit of the Hospital Universitario 12 de Octubre on the waiting list for endoscopic intervention on stenosis.
- Stenosis grade ≥ 3 and Borg scale score > 2.
Exclusion Criteria:
- Presence of relevant comorbidities (uncontrolled ischemic heart disease, ventricular dysfunction, pneumopathies with severe respiratory insufficiency, severe pulmonary hypertension).
- Inability to perform the test due to severe dyspnea or need for emergency intervention.
- Patient on continuous mechanical ventilation, invasive or non-invasive.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Airway Stenosis
Patients with lower airway stenosis on waiting list for endoscopic intervention on stenosis by respiratory endoscopy unit. |
Treatment for 30 minutes with Heliox from a commercial tank (Oxhelⓒ, Air Liquideⓒ) with a fixed mixture of 70% helium and 30% oxygen with non-rebreather mask or reservoir bag at a flow of 12-15 lpm.
Andra namn:
Treatment for 30 minutes with oxygen at FiO2 of 31% with Venturi mask.
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Changes in Neural Ventilatory Drive (%):
Tidsram: 30 minutes with Heliox and 30 minutes with Oxygen 31%
|
Percentage over the Root Mean Square peak for parasternal electromyography (EMG): averaged of the square root of the peak value and the area under the curve of parasternal EMG (%RootMeanSquare) adjusted for respiratory frequency, as a surrogate of diaphragmatic EMG, and sternocleidomastoid EMG, which will give us information on accessory muscle activation. |
30 minutes with Heliox and 30 minutes with Oxygen 31%
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Diaphragmatic excursion assessed with ultrasound
Tidsram: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
|
Assessment of muscular effort by measuring the diaphragmatic excursion (mm) at tidal volume and at vital capacity. |
At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
|
|
Thickening fraction of the diaphragm assessed by ultrasound
Tidsram: At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
|
Assessment of muscular effort by measuring the thickening fraction of the diaphragm in the apposition zone (%). |
At minute 15 during the Heliox test and at minute 15 during the Oxygen 31% test.
|
|
Changes in thoracoabdominal synchrony
Tidsram: Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Assessment of thoracoabdominal synchrony using thoracic and abdominal belts by calculating the phase angle with the Lissajoux loop method (plotting abdominal motion on the x-axis against thoracic motion on the y-axis). |
Phase angle was calculated from 10 consecutive breaths at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Borg Scale Dyspnea evolution (points)
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Degree of dyspnea will be determined by this validated scale with a result between 1 and 10 points.0: Not at all 0.5: Very, very light (hardly noticeable) 1: Very light, 2: Light, 3: Moderate , 4: Somewhat intense, 5: Intense, 6: Between 5 and 7, 7: Very intense, 8: Between 7 and 9, 9: Very, very intense (almost maximum ), 10: Maximum |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Oxygen saturation
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Measured by pulse-oximetry |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Transcutaneous partial pressure of carbon dioxide
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Transcutaneous monitor uses a noninvasive technique to measure the skin-surface partial pressure of carbon dioxide (PtcCO2) |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Blood pressure
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Non-invasive measurement with a sphygmomanometer |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Heart rate
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
number of beats per minute |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
|
Respiratory rate
Tidsram: Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Number of breaths per minute |
Basal value and at minutes 1, 5, 15 and 30 during the Heliox test and the Oxygen 31% test.
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Marta Corral Blanco, MD, Hospital 12 de Octubre
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HELIOX ON AIRWAY STENOSIS
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .